Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Pisters

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|August 1, 1997
Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology TeamK M Pisters, M G Kris, P A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancerP A Francis, J R Rigas, M G Kris, et al.
American Journal of Clinical Oncology|August 1, 1995
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapyV A Miller, J R Rigas, K M Pisters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I trial of oral green tea extract in adult patients with solid tumorsK M Pisters, R A Newman, B Coldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatinS A Laurie, D G Pfister, M G Kris, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancerV A Miller, J R Rigas, W P Tong, et al.
Cancer|February 15, 1995
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerV A Miller, J R Rigas, P A Francis, et al.
Investigational New Drugs|June 9, 1999
Phase I study of paclitaxel administered by ten-day continuous infusionR J Shade, K M Pisters, M H Huber, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2)M G Kris, K M Pisters, R J Ginsberg, et al.
Clinical Lung Cancer|December 6, 2003
ZD1839 (Iressa) in non-small-cell lung cancerR S Herbst, F R Khuri, F V Fossella, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|August 1, 1997
Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology TeamK M Pisters, M G Kris, P A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancerP A Francis, J R Rigas, M G Kris, et al.
American Journal of Clinical Oncology|August 1, 1995
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapyV A Miller, J R Rigas, K M Pisters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I trial of oral green tea extract in adult patients with solid tumorsK M Pisters, R A Newman, B Coldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatinS A Laurie, D G Pfister, M G Kris, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancerV A Miller, J R Rigas, W P Tong, et al.
Cancer|February 15, 1995
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerV A Miller, J R Rigas, P A Francis, et al.
Investigational New Drugs|June 9, 1999
Phase I study of paclitaxel administered by ten-day continuous infusionR J Shade, K M Pisters, M H Huber, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2)M G Kris, K M Pisters, R J Ginsberg, et al.
Clinical Lung Cancer|December 6, 2003
ZD1839 (Iressa) in non-small-cell lung cancerR S Herbst, F R Khuri, F V Fossella, et al.
Pageof 5